![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Tenofovir Plasma Pharmacokinetics in AIDS Clinical Trials Group Study A5202
|
|
|
Reported by Jules Levin
!AC 2012 Wash DC July 22-27
Charles S Venuto1,2, Qing Ma2, Eric S Daar3, Paul E Sax4, Margaret A Fischl5, Ann C Collier6, Katie Mollan7, Kimberly Smith8, Camlin Tierney7, Gene D Morse2, and the ACTG 5202 Protocol Team 1University of Rochester Medical Center, Rochester, NY; 2School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY; 3Harbor-UCLA Medical Center, Los Angeles, CA; 4Brigham and Women's Hospital, Harvard Medical School, Boston, MA; 5University of Miami, Miami FL; 6University of Washington Medical Center, Seattle, WA; 7Statistical Data Analysis Center, Harvard School of Public Health, Boston, MA; 8Rush University Medical Center, Chicago, IL
![IAC1.gif](../images/081012/081012-2/IAC1.gif)
![IAC2.gif](../images/081012/081012-2/IAC2.gif)
![IAC3.gif](../images/081012/081012-2/IAC3.gif)
![IAC4.gif](../images/081012/081012-2/IAC4.gif)
![IAC5.gif](../images/081012/081012-2/IAC5.gif)
![IAC6.gif](../images/081012/081012-2/IAC6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|